நிறுவனம் பெருநிறுவன ப்ரெஸெஂடேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் பெருநிறுவன ப்ரெஸெஂடேஶந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் பெருநிறுவன ப்ரெஸெஂடேஶந் Today - Breaking & Trending Today

Sutro Biopharma Announces Additional Data for Dose-Escalation Phase 1 Study of STRO-002 to be Presented at ASCO 2021


Share this article
Share this article
SOUTH SAN FRANCISCO, Calif., May 19, 2021 /PRNewswire/  Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced additional data from the Company s dose-escalation cohort of the Phase 1 study of STRO-002, a folate receptor alpha (FolRα) targeting antibody-drug conjugate (ADC) for patients with advanced, progressive ovarian cancer; the data will also be presented as a poster at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting to be held on June 4-8, 2021. ....

United States , Sutro Biopharma , Maggie Beller , Anniej Chang , Arturo Molina , R Wendel Naumann , Sutro Xpress , American Society Of Clinical Oncology , Celgene Corporation , Company Corporate Presentation , Atrium Health , Exchange Commission , Merck Kga , Gynecologic Oncology Research At Levine Cancer Institute , Sutro Biopharma Inc , Merck Kgaa , Bristol Myers Squibb , American Society , Clinical Oncology , Bill Newell , Chief Executive Officer , Escalation Cohort , Chief Medical Officer , Corporate Presentation , Escalation Study , Folate Receptor ,